Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Brivaracetam adjunctive therapy in partial-onset seizures
2010-019361-28Phase 3Completed
- Sponsor
- UCB
- Start
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brivaracetam in Focal Onset Epilepsy and focal-onset epileptic seizures (3 arms), sponsored by UCB. Primary endpoints: Partial-onset seizure frequency standardized to 28 days, Percent reduction in partial-onset seizure frequency over placebo and 1 more. Started Oct 2010; status: completed.
02
Drugs
brivaracetam
03
Conditions
Focal Onset Epilepsyfocal-onset epileptic seizures
Beyond the preview
Go deeper on 2010-019361-28.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-019361-28.